In Vitro Studies of Sickle Cell Disease Drugs

Study title

Find new drugs for the treatment of SCD.

SCD patients with hemoglobin SS, 5 years and up with a Hemoglobin F less than 10% and not receiving hydroxyurea or transfusion therapies.

PI: Dr. Toshio Asakura

SC: Tannoa Jackson

Sponsor: National Institutes of Health

215-590-3423